Kouya Yamaki Selected Research

Kouya Yamaki Research Topics

Disease

6	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2014
5	Arthritis (Polyarthritis) 03/2009 - 08/2003
5	Acute Lung Injury 03/2005 - 11/2003
2	Immune System Diseases (Immune Disorders) 01/2016 - 10/2014
2	Leukemia 04/2015 - 03/2010
2	Asthma (Bronchial Asthma) 09/2007 - 01/2007
2	Inflammation (Inflammations) 07/2004 - 12/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023
1	Skin Manifestations 01/2023
1	Lymphoma (Lymphomas) 02/2022
1	Hypothermia 01/2016
1	Hypersensitivity (Allergy) 04/2015
1	Diarrhea 02/2014
1	Food Hypersensitivity (Food Allergy) 02/2014
1	Hyperplasia 02/2014
1	Allergic Rhinitis 09/2007
1	Rheumatoid Arthritis 07/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2004
1	Body Weight (Weight, Body) 04/2004
1	Atherosclerosis 04/2004
1	Pulmonary Edema 11/2003
1	Pneumonia (Pneumonitis) 11/2003

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 01/2023 - 08/2003
6	Immunoglobulin G (IgG)IBA 01/2023 - 08/2003
5	OvalbuminIBA 10/2023 - 01/2014
5	Immunoglobulin A (IgA)IBA 02/2022 - 01/2014
5	Immunoglobulin E (IgE)IBA 01/2016 - 01/2014
5	LipopolysaccharidesIBA 03/2005 - 11/2003
3	AntibodiesIBA 10/2023 - 03/2009
3	CytokinesIBA 04/2015 - 11/2004
3	Vehicle Emissions (Emissions, Vehicle)IBA 01/2007 - 11/2004
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2007 - 11/2004
2	AllergensIBA 10/2023 - 04/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 01/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 01/2016
2	EpitopesIBA 04/2015 - 03/2009
2	Interleukin-10 (Interleukin 10)IBA 02/2014 - 12/2003
2	RolipramIBA 01/2007 - 07/2004
2	Organic Chemicals (Chemicals, Organic)IBA 01/2007 - 11/2004
1	Imiquimod (Aldara)FDA LinkGeneric 10/2023
1	Platelet Activating FactorIBA 01/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	Histamine H1 AntagonistsIBA 01/2016
1	fluorescein-ovalbuminIBA 01/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2016
1	ruxolitinibIBA 02/2014
1	Janus Kinase InhibitorsIBA 02/2014
1	Interleukin-4 (Interleukin 4)IBA 02/2014
1	Interleukin-9 (Interleukin 9)IBA 02/2014
1	Interleukin-13IBA 02/2014
1	Janus KinasesIBA 02/2014
1	VaccinesIBA 01/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	perfluorooctanoic acidIBA 03/2010
1	perfluorooctaneIBA 03/2010
1	CollagenIBA 03/2009
1	Collagen Type II (Type II Collagen)IBA 03/2009
1	Indicators and Reagents (Reagents)IBA 03/2009
1	Butylated Hydroxytoluene (BHT)IBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2007
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2007
1	15-deoxyprostaglandin J2IBA 03/2005
1	Complementary DNA (cDNA)IBA 11/2004
1	Calcium-Binding ProteinsIBA 11/2004
1	Lipocalin-2IBA 11/2004
1	Triglycerides (Triacylglycerol)IBA 04/2004
1	Nitrogen DioxideIBA 04/2004
1	CholesterolIBA 04/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2004
1	ChemokinesIBA 01/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 08/2003

Therapy/Procedure

2	Intravenous Injections 01/2016 - 04/2015
1	Intravenous Administration 01/2023
1	Oral Administration 02/2014